Latest Warfarin Stories
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Software is designed and developed in association with national patient safety guidelines to reduce adverse events and re-admissions. ST. PAUL, Minn., Feb.
While the surveyed physicians were pleased that new blood thinning options such as Xarelto are now available, there was concern about the lack of an antidote to reverse internal bleeding, a side
The report’s publication comes as dozens of people pursue Xarelto lawsuits for internal bleeding and other serious complications allegedly related to its use. New
TOKYO and PARSIPPANY, N.J., Feb.
The Firm is representing a number of Xarelto lawsuit plaintiffs who allegedly experienced dangerous internal bleeding and other complications related to their use of the blood thinner.
Dr. Larry Hsu Elected to Board of Directors MENLO PARK, Calif., Feb.
Xarelto Drug Safety Label Warns Bleeding Is A Common Adverse Reaction Of The Blood Thinner And Xarelto Bleeding Side-Effects Lawsuits Claim The Anticoagulant Does Not Have An Antidote Should Severe
The study comes as dozens of plaintiffs, including a number being represented by the Firm, pursue Xarelto lawsuits after allegedly suffering uncontrollable bleeding and other complications due
The Firm is currently representing plaintiffs in Xarelto lawsuits who allegedly suffered life-threatening and uncontrollable episodes of internal bleeding due to their use of the blood thinner.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.